- Home
- MUJ vs ARCT Comparison
MUJ vs ARCT Comparison
Compare MUJ & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUJ
- ARCT
- Stock Information
- Founded
- MUJ 1998
- ARCT 2013
- Country
- MUJ United States
- ARCT United States
- Employees
- MUJ N/A
- ARCT N/A
- Industry
- MUJ Investment Bankers/Brokers/Service
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- MUJ Finance
- ARCT Health Care
- Exchange
- MUJ Nasdaq
- ARCT Nasdaq
- Market Cap
- MUJ 619.6M
- ARCT 526.5M
- IPO Year
- MUJ N/A
- ARCT N/A
- Fundamental
- Price
- MUJ $11.62
- ARCT $11.20
- Analyst Decision
- MUJ
- ARCT Buy
- Analyst Count
- MUJ 0
- ARCT 10
- Target Price
- MUJ N/A
- ARCT $35.25
- AVG Volume (30 Days)
- MUJ 108.0K
- ARCT 2.1M
- Earning Date
- MUJ 01-01-0001
- ARCT 11-07-2025
- Dividend Yield
- MUJ 4.36%
- ARCT N/A
- EPS Growth
- MUJ N/A
- ARCT N/A
- EPS
- MUJ N/A
- ARCT N/A
- Revenue
- MUJ N/A
- ARCT $122,122,000.00
- Revenue This Year
- MUJ N/A
- ARCT N/A
- Revenue Next Year
- MUJ N/A
- ARCT $34.32
- P/E Ratio
- MUJ N/A
- ARCT N/A
- Revenue Growth
- MUJ N/A
- ARCT N/A
- 52 Week Low
- MUJ $9.74
- ARCT $8.04
- 52 Week High
- MUJ $11.70
- ARCT $24.17
- Technical
- Relative Strength Index (RSI)
- MUJ 60.05
- ARCT 32.09
- Support Level
- MUJ $11.50
- ARCT $9.19
- Resistance Level
- MUJ $11.62
- ARCT $12.10
- Average True Range (ATR)
- MUJ 0.08
- ARCT 1.81
- MACD
- MUJ -0.02
- ARCT -1.24
- Stochastic Oscillator
- MUJ 57.14
- ARCT 13.44
About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.
BlackRock MuniHoldings New Jersey Quality Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund mainly invests in long-term, investment-grade municipal obligations exempt from U.S federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and New Jersey personal income taxes, with remaining maturities of one year or more at the time of investment. The rest of its managed assets can be invested in securities that are rated below investment grade (or similar instruments), or invested directly in securities or synthetically through the use of derivatives.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.